SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
斜杠青年ZH
Lv5
1050 积分
2022-03-15 加入
最近求助
最近应助
互助留言
Cyclodextrin polymers: Structure, synthesis, and use as drug carriers
3小时前
已完结
Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis
14天前
已完结
Algal carbohydrate polymers: Catalytic innovations for sustainable development
1个月前
已完结
Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury
2个月前
已完结
PD-1/PD-L1 inhibitors-associated cardiac adverse events: a retrospective and real-world study based on the FDA Adverse Event Reporting System (FAERS)
5个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
9个月前
已完结
Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
10个月前
已完结
Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment
10个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
11个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
11个月前
已完结
没有进行任何应助
感谢
3小时前
感谢,感谢
14天前
感谢,感谢
1个月前
感谢,感谢,感谢
5个月前
感谢,感谢,感谢
9个月前
感谢,感谢,感谢,速度真快,速度真快
11个月前
感谢,感谢,感谢,点赞,点赞,点赞,点赞
11个月前
感谢,感谢
1年前
感谢,感谢,感谢,点赞,点赞,点赞,速度真快,帮大忙了
1年前
感谢,感谢
1年前
最近帖子
最近评论
综合讨论
细胞相容性试验
1年前
没有发布任何评论